Table 3. SIRs of receiving social security benefits available from 1992 to 2006 (2002–2007 for medical rehabilitation benefits) among 5-year cancer survivors.
| Attendance benefits | Basic benefits | Disability pension | Medical rehabilitation benefits | |
|---|---|---|---|---|
| Obs./SIR (95% CI) | Obs./SIR (95% CI) | Obs./SIR (95% CI) | Obs./SIR (95% CI) | |
|
Neoplasm | ||||
| Men | 160/3130.5 (2681.2–3655.2) | 152/2429.6 (2072.7–2848.5) | 93/1306.4 (1054.4–1600.5) | 11/10.2 (5.1–18.2) |
| Women | 120/3573.0 (2987.7–4273.1) | 123/1954.4 (1637.8–2332.2) | 99/1640.3 (1333.4–1997.0) | 10/5.7 (2.7–10.5) |
| Total |
280/3328.3 (2960.7–3742.3) |
275/2176.4 (1933.8–2449.5) |
192/1460.0 (1267.4–1681.8) |
21/7.3 (4.5–11.1) |
|
Infectious and parasitic disease | ||||
| Men | — | 1/22.8 (0.6–127.3) | — | 17/2.6 (1.5–4.2) |
| Women | — | 0/0 (0–64.4) | — | 27/3.2 (2.3–4.8) |
| Total |
— |
1/10.4 (0.3–58.0) |
— |
44/3.1 (2.2–4.1) |
|
Endocrine, nutritional and metabolic disease and immunity disorder | ||||
| Men | 6/4.5 (1.6–9.8) | 8/2.3 (1.0–4.6) | 5/8.5 (2.8–19.8) | — |
| Women | 2/2.1 (0.3–7.7) | 5/1.9 (0.6–4.4) | 9/12.6 (5.7–23.9) | 1/4.0 (0.1–22.4) |
| Total |
8/3.5 (1.5–7.0) |
13/2.1 (1.0–3.5) |
14/10.6 (5.8–17.8) |
1/2.3 (0–8.5) |
|
Mental disorders | ||||
| Men | 10/1.7 (0.8–3.2) | 7/1.5 (0.6–3.1) | 36/1.6 (1.1–2.2) | 12/0.7 (0.4–1.2) |
| Women | 6/2.0 (0.8–4.5) | 11/3.2 (1.6–5.7) | 30/1.8 (1.2–2.6) | 8/0.5 (0.2–1.0) |
| Total |
16/1.9 (1.1–3.1) |
18/2.2 (1.3–3.5) |
66/1.7 (1.3–2.2) |
20/0.6 (0.4–0.9) |
|
Disease of the nervous system | ||||
| Men | 9/3.2 (1.5–6.2) | 12/4.5 (2.3–7.9) | 14/5.5 (3.0–9.2) | 2/3.6 (0.4–13.1) |
| Women | 8/5.7 (2.4–11.2) | 10/4.8 (2.3–8.8) | 14/4.4 (2.4–7.3) | 1/1.3 (0–7.3) |
| Total |
17/4.2 (2.4–6.7) |
22/4.7 (2.9–7.1) |
28/4.8 (3.2–7.0) |
3/2.3 (0.5–6.6) |
|
Disease of the sense organs | ||||
| Men | 3/3.9 (0.8–11.4) | 7/5.7 (2.3–11.8) | 2/5.1 (0.6–18.4) | 1/1.4 (0–5.0) |
| Women | 7/11.9 (4.8–24.5) | 15/13.6 (7.6–22.4) | 1/2.1 (0.1–11.8) | 2/1.7 (0.2–6.2) |
| Total |
10/7.4 (3.5–13.6) |
22/9.5 (5.9–14.3) |
3/3.4 (0.7–10.0) |
3/1.6 (0.1–4.5) |
|
Disease of the digestive system | ||||
| Men | — | 5/2.0 (0.7–4.7) | — | 9/3.8 (1.7–7.1) |
| Women | — | 8/2.1 (1.0–4.0) | 3/5.0 (1.0–14.5) | 3/1.2 (0.2–3.5) |
| Total |
— |
14/2.0 (1.1–3.4) |
3/3.4 (0.7–9.9) |
12/2.4 (1.3–4.3) |
|
Disease of the genitourinary system | ||||
| Men | — | 1/18.6 (0.5–103.6) | — | 40/5.5 (4.0–7.5) |
| Women | — | 1/9.8 (0.2–54.7) | 1/7.8 (0.2–43.4) | 37/3.7 (2.6–5.0) |
| Total |
— |
2/12.6 (0.2–35.1) |
1/5.1 (0.1–28.4) |
77/4.4 (3.5–5.5) |
|
Disease of the musculoskeletal system and connective tissue | ||||
| Men | 3/8.5 (1.7–24.9) | 4/3.3 (0.9–8.6) | 4/1.9 (0.5–4.8) | 2/1.3 (0.2–4.6) |
| Women | 3/4.9 (1.0–14.2) | 9/4.1 (1.9–7.8) | 13/2.5 (1.3–4.2) | 1/0.6 (0–3.2) |
| Total |
6/6.1 (2.2–13.2) |
13/3.8 (2.0–6.4) |
17/2.2 (1.3–3.6) |
3/0.9 (0.1–2.2) |
|
Disease of the skin and subcutaneous tissue | ||||
| Men | — | 6/1.7 (0.6–3.7) | — | 51/1.0 (0.8–1.3) |
| Women | 2/5.3 (0.6–19.0) | 7/1.5 (0.6–3.1) | — | 54/0.8 (0.6–1.1) |
| Total |
2/2.3 (0–6.3) |
13/1.6 (0.8–2.7) |
— |
105/0.9 (0.8–1.1) |
|
Certain conditions origination in the perinatal period | ||||
| Men | — | — | — | 56/0.9 (0.7–1.2) |
| Women | — | — | — | 59/0.8 (0.6–1.1) |
| Total |
— |
— |
— |
115/0.9 (0.7–1.0) |
|
Injury and poisoning | ||||
| Men | 14/18.1 (9.9–30.4) | 24/12.1 (7.8–18.1) | 6/2.0 (0.8–4.5) | 17/2.7 (1.6–4.3) |
| Women | 14/42.9 (23.5–72.0) | 20/21.3 (13.0–32.9) | 4/2.1 (0.6–5.3) | 18/1.4 (0.8–2.2) |
| Total |
28/26.0 (17.3–37.6) |
44/15.3 (11.1–20.6) |
10/2.1 (1.0–3.8) |
35/1.8 (1.3–2.5) |
|
Others | ||||
| Men | 2/0.9 (0.1–3.1) | 11/4.7 (2.3–8.4) | 1/1.0 (0–3.6) | 1/0.2 (0–1.3) |
| Women | 3/2.8 (0.6–8.3) | 9/4.7 (2.1–8.9) | 6/5.0 (1.8–10.9) | 10/2.1 (1.0–3.8) |
| Total | 5/1.5 (0.5–3.5)a | 20/4.7 (2.8–7.3)b | 7/3.1 (1.3–6.4)c | 11/1.2 (0.6–2.2)d |
Abbreviations: CI=confidence interval; ICD-7=International Classification of Diseases-7; obs.=observed; SIR=standardised incidence ratio.
a
This includes diseases of the circulatory system (n=2), diseases of the respiratory system (n=2), and symptoms, signs and ill-defined conditions (n=1).
b
This includes diseases of the circulatory system (n=9), diseases of the respiratory system (n=3), and symptoms, signs and ill-defined conditions (n=8).
c
This includes diseases of the circulatory system (n=2), diseases of the respiratory system (n=2), and symptoms, signs and ill-defined conditions (n=3).
d
This includes diseases of the blood and blood-forming organs (n=6), diseases of the respiratory system (n=1), and symptoms, signs and ill-defined conditions (n=4).